Quanterix Corporation (QTRX) Income Statement

NASDAQ: QTRXRevenue, profits, margins and EPS over 10 years.

QTRX 2025 at a glance

Fiscal year ended December 31, 2025 · U.S. dollars
Revenue+2.4%
$138.7M
2025 · hover or tap a bar for each year
2016: $17.6M (+44.4%)2017: $22.9M (+30.1%)2018: $37.6M (+64.5%)2019: $56.7M (+50.8%)2020: $86.4M (+52.2%)2021: $110.6M (+28.0%)2022: $105.5M (−4.6%)2023: $121.1M (+14.8%)2024: $135.4M (+11.8%)2025: $138.7M (+2.4%)
20162025
Gross profit−20.2%
$64.7M
2025 · hover or tap a bar for each year
2016: $7.7M (+35.6%)2017: $10.0M (+28.9%)2018: $18.0M (+80.1%)2019: $26.8M (+49.2%)2020: $48.2M (+79.5%)2021: $61.7M (+28.1%)2022: $45.4M (−26.5%)2023: $73.0M (+60.9%)2024: $81.1M (+11.1%)2025: $64.7M (−20.2%)
20162025
Operating income
−$109.8M
2025 · hover or tap a bar for each year
2016: −$21.7M2017: −$26.0M2018: −$31.6M2019: −$41.6M2020: −$31.6M2021: −$58.6M2022: −$104.3M2023: −$46.0M2024: −$52.6M2025: −$109.8M
20162025
Net income
−$107.2M
2025 · hover or tap a bar for each year
2016: −$23.2M2017: −$27.0M2018: −$31.0M2019: −$40.8M2020: −$31.5M2021: −$57.7M2022: −$99.6M2023: −$28.4M2024: −$38.5M2025: −$107.2M
20162025
EPS (diluted)
−$2.20
2025 · hover or tap a bar for each year
2016: −$1.432017: −$2.182018: −$1.412019: −$1.612020: −$1.362021: −$1.582022: −$2.062023: −$0.812024: −$1.032025: −$2.20
20162025
Net profit margin−48.8 pts
−77.3%
2025 · hover or tap a point for each year
2016: −131.8% (−0.9 pts)2017: −118.1% (+13.7 pts)2018: −82.5% (+35.6 pts)2019: −71.9% (+10.6 pts)2020: −36.5% (+35.4 pts)2021: −52.2% (−15.7 pts)2022: −94.4% (−42.2 pts)2023: −23.4% (+71.0 pts)2024: −28.4% (−5.0 pts)2025: −77.3% (−48.8 pts)
20162025

QTRX revenue and net income

RevenueNet incomeNet margin (right axis)

Where QTRX's revenue goes

2025
Revenue
$138.7M100.0%
Cost of revenue
−$73.9M−53.3%
Gross profit
$64.7M46.7%
Research & development
−$35.9M−25.9%
Sales, general & admin
−$138.9M−100.1%
Operating income
−$109.8M−79.2%
Interest & other expense
−$2.5M−1.8%
Income taxes
$5.1M3.7%
Net income
−$107.2M−77.3%

Each bar shows an amount and its share of revenue. QTRX kept −77.3% of revenue as net income.

QTRX profit margins

GrossOperatingNet

QTRX growth rates

to 2025
1 year3 years5 years10 years
Revenue+2.4%+9.5%+9.9%+27.5%
Gross profit−20.2%+12.6%+6.1%+27.5%
Operating income————
Net income————
EPS (diluted)————

1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.

QTRX quarterly EPS vs estimates

Reported EPSAnalyst estimate

Quanterix beat the analyst EPS estimate in 3 of the last 8 quarters. Next report: November 9, 2026 (estimate $-0.49).

QTRX income statement

Quanterix Corporation annual income statement
2025202420232022202120202019201820172016
Revenue$138.7M$135.4M$121.1M$105.5M$110.6M$86.4M$56.7M$37.6M$22.9M$17.6M
Cost of revenue$73.9M$54.3M$48.1M$60.2M$48.8M$38.2M$29.9M$19.6M$12.9M$9.8M
Gross profit$64.7M$81.1M$73.0M$45.4M$61.7M$48.2M$26.8M$18.0M$10.0M$7.7M
Research & development$35.9M$31.1M$26.1M$26.8M$28.0M$20.2M$16.2M$15.3M$16.3M$17.0M
Sales, general & admin$138.9M$104.6M$93.1M$91.9M$92.3M$59.6M$52.2M$33.8M$19.7M$12.5M
Total operating expenses$174.5M$133.7M$119.0M$149.6M$120.3M$79.8M$68.4M$49.1M$36.0M$29.5M
Operating income−$109.8M−$52.6M−$46.0M−$104.3M−$58.6M−$31.6M−$41.6M−$31.6M−$26.0M−$21.7M
Interest income$8.6M$14.7M$15.8M$5.1M——$627,000$46,000$952,000$1.3M
Interest expense——$15.8M$5.1M$403,000$273,000$627,000$46,000$952,000$1.3M
Income before taxes−$112.3M−$38.1M−$27.6M−$99.4M−$57.7M−$31.9M−$41.0M−$31.0M−$27.0M−$23.2M
Income taxes−$5.1M$434,000$719,000$164,000−$36,000−$376,000−$187,000$25,000$408,000$1.1M
Net income−$107.2M−$38.5M−$28.4M−$99.6M−$57.7M−$31.5M−$40.8M−$31.0M−$27.0M−$23.2M
EBITDA−$93.3M−$29.7M−$36.4M−$67.2M−$53.7M−$27.3M−$38.6M−$30.2M−$25.6M−$21.4M
EPS (diluted)−$2.20−$1.03−$0.81−$2.06−$1.58−$1.36−$1.61−$1.41−$2.18−$1.43
Gross margin46.7%59.9%60.3%43.0%55.8%55.8%47.3%47.8%43.7%44.1%
Operating margin−79.2%−38.8%−38.0%−98.8%−53.0%−36.6%−73.3%−83.8%−113.7%−123.5%
Net margin−77.3%−28.4%−23.4%−94.4%−52.2%−36.5%−71.9%−82.5%−118.1%−131.8%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in QTRX's financial statements (latest annual report filed March 2, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.

QTRX financial results

In fiscal year 2025 (ended December 31, 2025), Quanterix reported revenue of $138.7 million, up 2.4% from the year before. It had a net loss of $107.2 million, a net profit margin of −77.3%. Diluted earnings per share came to −$2.20. Over five years revenue grew at an average rate of 9.9% a year.

See the QTRX stock overview for the latest quote and news, or the QTRX chart for price history and technical indicators.

QTRX income statement FAQ

What is Quanterix's annual revenue?

Quanterix reported total revenue of $138.7 million for fiscal year 2025, which ended on December 31, 2025. That was up 2.4% from $135.4 million the previous year.

Is Quanterix profitable?

No. Quanterix reported a net loss of $107.2 million in fiscal 2025, a net profit margin of −77.3%; its operating margin was −79.2%.

What is Quanterix's gross margin?

Quanterix's gross margin was 46.7% in fiscal 2025: for every $100 of revenue, Quanterix kept $47 after the direct cost of its products and services.

How much does Quanterix spend on research and development?

Quanterix spent $35.9 million on research and development in fiscal 2025, 25.9% of revenue.

How fast is Quanterix growing?

Revenue grew 9.9% a year on average over the last five fiscal years, from $86.4 million to $138.7 million.

What are Quanterix's earnings per share?

Quanterix earned $-2.20 per diluted share in fiscal 2025, compared with $-1.03 a year earlier.

When will Quanterix report its next earnings?

Quanterix is expected to report results for the quarter ending September 30, 2026 on November 9, 2026 before the market opens.

When does Quanterix's fiscal year end?

Quanterix's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 2, 2026.

Medical Devices income statements